Polyvalent immunoglobulins: challenges and perspectives.
作者信息
Quinti Isabella, Coluzzi Serelina, Pulvirenti Federica, Prezzo Alessandro, Girelli Gabriella
机构信息
Department of Molecular Medicine, "Sapienza" University of Rome, Rome, Italy.
Unit of Immunohaematology and Transfusion Medicine, "Sapienza" University of Rome, Rome, Italy.
出版信息
Blood Transfus. 2013 Sep;11 Suppl 4(Suppl 4):s40-4. doi: 10.2450/2013.008s.
Abstract
摘要
相似文献
1
Polyvalent immunoglobulins: challenges and perspectives.多价免疫球蛋白：挑战与展望。
Blood Transfus. 2013 Sep;11 Suppl 4(Suppl 4):s40-4. doi: 10.2450/2013.008s.
2
IgG replacement therapy, no size fits all.免疫球蛋白替代疗法，并非一概而论。
Clin Immunol. 2011 May;139(2):107-9. doi: 10.1016/j.clim.2011.02.020. Epub 2011 Mar 3.
3
Clinical use of polyvalent immunoglobulins.多价免疫球蛋白的临床应用。
Blood Transfus. 2013 Sep;11 Suppl 4(Suppl 4):s33-9. doi: 10.2450/2013.007s.
4
The demand for polyvalent immunoglobulins in Italy.意大利对多价免疫球蛋白的需求。
Blood Transfus. 2013 Sep;11 Suppl 4(Suppl 4):s45-54. doi: 10.2450/2013.009s.
5
A multi-centre study of efficacy and safety of Intratect®, a novel intravenous immunoglobulin preparation.一项评估新型静脉用免疫球蛋白制剂 Intratect®的疗效和安全性的多中心研究。
Clin Exp Immunol. 2010 Sep;161(3):512-7. doi: 10.1111/j.1365-2249.2010.04187.x.
6
Cationized IVIg as a potential substitute to IVIg for the treatment of experimental immune thrombocytopenia.阳离子化 IVIg 作为治疗实验性免疫性血小板减少症的 IVIg 替代物的潜在选择。
Int Immunopharmacol. 2013 Aug;16(4):409-13. doi: 10.1016/j.intimp.2013.04.023. Epub 2013 May 8.
7
Subcutaneous immunoglobulin in responders to intravenous therapy with chronic inflammatory demyelinating polyradiculoneuropathy.慢性炎症性脱髓鞘性多发性神经根神经病患者对静脉注射治疗有反应者皮下免疫球蛋白。
Eur J Neurol. 2013 May;20(5):836-42. doi: 10.1111/ene.12080. Epub 2013 Jan 7.
8
Immunoglobulin therapy: methods of delivery.免疫球蛋白疗法：给药方法。
J Allergy Clin Immunol. 2008 Nov;122(5):1038-9. doi: 10.1016/j.jaci.2008.08.012. Epub 2008 Sep 19.
9
Immunoglobulins and sepsis.免疫球蛋白与脓毒症。
Intensive Care Med. 2018 Nov;44(11):1923-1925. doi: 10.1007/s00134-018-5047-6. Epub 2018 Jan 18.
10
Privigen® has similar pharmacokinetic properties in primary and secondary immune deficiency.普乐复®在原发性和继发性免疫缺陷中具有相似的药代动力学特性。
Int Immunopharmacol. 2019 Jan;66:119-126. doi: 10.1016/j.intimp.2018.11.008. Epub 2018 Nov 15.
引用本文的文献
1
Safety and tolerability of pooled human immune globulins after topical ophthalmic administration in New Zealand White rabbits.新西兰白兔经眼部局部给药后的人免疫球蛋白的安全性和耐受性。
Cutan Ocul Toxicol. 2024 Sep;43(3):227-231. doi: 10.1080/15569527.2024.2381207. Epub 2024 Jul 31.
2
Acupoint Autohemotherapy Attenuates DNCB-Induced Atopic Dermatitis and Activates Regulatory T Cells in BALB/c Mice.穴位自血疗法减轻二硝基氯苯诱导的BALB/c小鼠特应性皮炎并激活调节性T细胞。
J Inflamm Res. 2024 May 9;17:2839-2850. doi: 10.2147/JIR.S454325. eCollection 2024.
3
The growing importance of achieving national self-sufficiency in immunoglobulin in Italy. The emergence of a national imperative.意大利实现免疫球蛋白国产化的重要性日益增加。这是一种国家的必然需求。
Blood Transfus. 2019 Nov;17(6):449-458. doi: 10.2450/2019.0265-19. Epub 2019 Dec 11.
4
Health-Related Quality of Life in Patients with CVID Under Different Schedules of Immunoglobulin Administration: Prospective Multicenter Study.不同免疫球蛋白给药方案下 CVID 患者的健康相关生活质量：前瞻性多中心研究。
J Clin Immunol. 2019 Feb;39(2):159-170. doi: 10.1007/s10875-019-0592-5. Epub 2019 Jan 15.
5
The demand for polyvalent immunoglobulins in Italy.意大利对多价免疫球蛋白的需求。
Blood Transfus. 2013 Sep;11 Suppl 4(Suppl 4):s45-54. doi: 10.2450/2013.009s.
6
Plasma-derived medicinal products: demand and clinical use.血浆衍生药物产品：需求与临床应用。
Blood Transfus. 2013 Sep;11 Suppl 4(Suppl 4):s2-5. doi: 10.2450/2013.002s.
本文引用的文献
1
Prioritization of evidence-based indications for intravenous immunoglobulin.静脉注射免疫球蛋白循证适应证的优先排序
J Clin Immunol. 2013 Aug;33(6):1033-6. doi: 10.1007/s10875-013-9912-3. Epub 2013 Jun 14.
2
A novel splice variant of FcγRIIa: a risk factor for anaphylaxis in patients with hypogammaglobulinemia.FcγRIIa 的一种新型剪接变异体：低丙种球蛋白血症患者发生过敏反应的一个风险因素。
J Allergy Clin Immunol. 2013 May;131(5):1408-16.e5. doi: 10.1016/j.jaci.2013.02.009. Epub 2013 Mar 29.
3
Intravenous immunoglobulin therapy: how does IgG modulate the immune system?静脉注射免疫球蛋白治疗：IgG 如何调节免疫系统？
Nat Rev Immunol. 2013 Mar;13(3):176-89. doi: 10.1038/nri3401. Epub 2013 Feb 15.
4
Intravenous immune globulin in autoimmune and inflammatory diseases.静脉注射免疫球蛋白在自身免疫性和炎性疾病中的应用
N Engl J Med. 2012 Nov 22;367(21):2015-25. doi: 10.1056/NEJMra1009433.
5
Intravenous immunoglobulin: exploiting the potential of natural antibodies.静脉注射用免疫球蛋白：开发天然抗体的潜力。
Autoimmun Rev. 2012 Sep;11(11):792-4. doi: 10.1016/j.autrev.2012.02.006. Epub 2012 Feb 12.
6
Hematologic toxicities associated with intravenous immunoglobulin therapy.与静脉注射免疫球蛋白治疗相关的血液学毒性。
Int Immunopharmacol. 2011 Nov;11(11):1663-7. doi: 10.1016/j.intimp.2011.07.024. Epub 2011 Aug 16.
7
Intravenous immunoglobulin therapy in rheumatic diseases.静脉注射免疫球蛋白治疗风湿性疾病。
Nat Rev Rheumatol. 2011 Jun;7(6):349-59. doi: 10.1038/nrrheum.2011.61. Epub 2011 May 10.
8
Key aspects for successful immunoglobulin therapy of primary immunodeficiencies.原发性免疫缺陷病免疫球蛋白治疗成功的关键因素。
Clin Exp Immunol. 2011 Jun;164 Suppl 2(Suppl 2):16-9. doi: 10.1111/j.1365-2249.2011.04390.x.
9
Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy.静脉注射免疫球蛋白在免疫缺陷中的应用：不仅仅是替代疗法。
Clin Exp Immunol. 2011 Jun;164 Suppl 2(Suppl 2):2-5. doi: 10.1111/j.1365-2249.2011.04387.x.
10
Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study.免疫球蛋白替代疗法对原发性抗体缺陷患者临床结局的影响：一项多中心前瞻性队列研究的结果。
J Clin Immunol. 2011 Jun;31(3):315-22. doi: 10.1007/s10875-011-9511-0. Epub 2011 Mar 2.
Zotero 插件